Systematic in vivo structure-function analysis of p300 in hematopoiesis

Blood

Volumn 114, Issue 23, 2009, Pages 4804-4812

  Kimbrel, Erin A ^a   Lemieux, Madeleine E ^a   Xia, Xiaobo ^a   Davis, Tina N ^a   Rebel, Vivienne I ^b   Kung, Andrew L ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HISTONE ACETYLTRANSFERASE; PROTEIN P300; CREBBP PROTEIN, HUMAN; E1A ASSOCIATED P300 PROTEIN; EP300 PROTEIN, MOUSE; HYBRID PROTEIN; SYNTHETIC DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; EMBRYONIC STEM CELL; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HEMATOPOIESIS; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; STEM CELL; ANIMAL; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL LINEAGE; CHEMISTRY; CHIMERA; CYTOLOGY; EMBRYO TRANSFER; GENE DELETION; GENE DOSAGE; GENE INACTIVATION; GENETICS; METABOLISM; MUTATION; NUDE MOUSE; PHYSIOLOGY; PLURIPOTENT STEM CELL; PROTEIN TERTIARY STRUCTURE; RADIATION CHIMERA; RNA SPLICING; STRUCTURE ACTIVITY RELATION; TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL LINEAGE; CHIMERA; CREB-BINDING PROTEIN; E1A-ASSOCIATED P300 PROTEIN; EMBRYO TRANSFER; EMBRYONIC STEM CELLS; FEMALE; GENE DOSAGE; GENE KNOCKOUT TECHNIQUES; GENES, SYNTHETIC; HEMATOPOIESIS; MICE; MICE, INBRED C57BL; MICE, NUDE; MUTATION; PLURIPOTENT STEM CELLS; PROTEIN STRUCTURE, TERTIARY; RADIATION CHIMERA; RECOMBINANT FUSION PROTEINS; RNA SPLICING; SEQUENCE DELETION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 74049152521     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-04-217794     Document Type: Article

References (50)

1. Huang ZQ, Li J, Sachs LM, Cole PA, Wong J. A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription. EMBO J. 2003;22(9):2146-2155.
2. Blobel GA. CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood. 2000;95(3):745-755.
3. Kraus WL, Manning ET, Kadonaga JT. Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates. Mol Cell Biol. 1999;19(12):8123-8135.
4. Zhu J, Emerson SG. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene. 2002;21(21):3295-3313.
5. Huang S, Qiu Y, Stein RW, Brandt SJ. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein. Oncogene. 1999;18(35):4958-4967.
6. Kasper LH, Brindle PK, Schnabel CA, Pritchard CE, Cleary ML, van Deursen JM. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Mol Cell Biol. 1999;19(1):764-776.
7. Deguchi K, Ayton PM, Carapeti M, et al. MOZTIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell. 2003;3(3):259-271.
8. Wang J, Iwasaki H, Krivtsov A, et al. Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. EMBO J. 2005;24(2):368-381.
9. Taki T, Sako M, Tsuchida M, Hayashi Y. The t(11; 16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood. 1997;89(11):3945-3950.
10. Zhang J, Kalkum M, Yamamura S, Chait BT, Roeder RG. E protein silencing by the leukemogenic AML1-ETO fusion protein. Science. 2004;305(5688):1286-1289.
11. Miller RW, Rubinstein JH. Tumors in Rubinstein-Taybi syndrome. Am J Med Genet. 1995;56(1):112-115.
12. Yao TP, Oh SP, Fuchs M, et al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell. 1998;93:361-372.
13. Oike Y, Takakura N, Hata A, et al. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood. 1999;93(9):2771-2779.
14. Rebel VIKA, Tanner EA, Yang H, Bronson RT, Livingston DM. Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proc Natl Acad Sci U S A. 2002;99(23):14789-14794.
15. Kung ALRV, Bronson RT, Ch'ng LE, Sieff CA, Livingston DM, Yao TP. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 2000;14(3):272-277.
16. Xu W, Fukuyama T, Ney PA, et al. Global transcriptional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cells. Blood. 2006;107(11):4407-4416.
17. Kasper LH, Fukuyama T, Biesen MA, et al. Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol Cell Biol. 2006;26(3):789-809.
18. Kang-Decker NTC, Boussouar F, Baker DJ, et al. Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency. Cancer Cell. 2004;5:177-189.
19. Shikama N, Lutz W, Kretzschmar R, et al. Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation. EMBO J. 2003;22(19):5175-5185.
20. Roth JF, Shikama N, Henzen C, et al. Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5. EMBO J. 2003;22(19):5186-5196.
21. Santillan DA, Theisler CM, Ryan AS, et al. Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype. Cancer Res. 2006;66(20):10032-10039.
22. Kasper LHBF, Ney PA, Jackson CW, Rehg J, van Deursen JM, Brindle PK. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. Nature. 2002;419:738-743.
23. Branda CS, Dymecki SM. Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell. 2004;6(1):7-28.
24. Hogan B, Beddington R, Costantini F, Lacy E. Manipulating the Mouse Embryo. 2nd ed. Plainview, NY: Cold Spring Harbor Laboratory Press; 1994.
25. StemCell Technologies. Isolation of Mesenchymal Progenitors from Mouse Compact Bone (for Catalog #19771). http://www.stemcell.com/technical/19771- bone%20crushing%20protocol.pdf. Accessed December 2007.
26. StemCell Technologies. http://www.stemcell.com/technical/28417-ltc-ic M.pdf. Accessed December 2007.
27. Cesari F, Rennekampff V, Vintersten K, et al. Elk-1 knock-out mice engineered by Flp recombinase-mediated cassette exchange. Genesis. 2004;38(2):87-92.
28. Schneider B, Koppius A, Sedlmeier R. Use of an exon-trapping vector for the evaluation of splice-site mutations. Mamm Genome. 2007;18(9):670-676.
29. Araki K, Araki M, Yamamura K. Site-directed integration of the cre gene mediated by Cre recombinase using a combination of mutant lox sites. Nucleic Acids Res. (http://nar.oxfordjournals.org/cgi/content/full/30/19/e103). 2002;30(19):e103.
30. Tsai FY, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994;371(6494):221-226.
31. Robertson SM, Kennedy M, Shannon JM, Keller G. A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development. 2000;127(11):2447-2459.
32. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 1996;84(2):321-330.
33. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404(6774):193- 197.
34. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997;91(5):661-672.
35. Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell. 2007;129(6):1081-1095.
36. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods. 2001;25(4):402-408.
37. Vittet D, Prandini MH, Berthier R, et al. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood. 1996;88(9):3424-3431.
38. Kennedy M, Firpo M, Choi K, et al. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature. 1997;386(6624):488-493.
39. Xie W, Song C, Young NL, et al. Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell. 2009;33(4):417-427.
40. Das C, Lucia MS, Hansen KC, Tyler JK. CBP/ p300-mediated acetylation of histone H3 on lysine 56. Nature. 2009;459(7243):113-117.
41. Levasseur DN, Wang J, Dorschner MO, Stamatoyannopoulos JA, Orkin SH. Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells. Genes Dev. 2008;22(5):575-580.
42. Pritsker M, Ford NR, Jenq HT, Lemischka IR. Genomewide gain-of-function genetic screen identifies functionally active genes in mouse embryonic stem cells. Proc Natl Acad Sci U S A. 2006;103(18):6946-6951.
43. Mucenski ML, McLain K, Kier AB, et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 1991;65(4):677-689.
44. Cheng JC, Kinjo K, Judelson DR, et al. CREB is a critical regulator of normal hematopoiesis and leukemogenesis. Blood. 2008;111(3):1182-1192.
45. Mukouyama Y, Chiba N, Hara T, et al. The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aorta-gonad-mesonephros region. Dev Biol. 2000;220(1):27-36.
46. Yoshida H, Kitabayashi I. Chromatin regulation by AML1 complex. Int J Hematol. 2008;87(1):19-24.
47. Wei L, Jamonnak N, Choy J, Wang Z, Zheng W. Differential binding modes of the bromodomains of CREB-binding protein (CBP) and p300 with acetylated MyoD. Biochem Biophys Res Commun. 2008;368(2):279-284.
48. Mujtaba S, He Y, Zeng L, et al. Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol Cell. 2004;13(2):251-263.
49. Hou T, Ray S, Lee C, Brasier AR. The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain. J Biol Chem. 2008;283(45):30725-30734.
50. Partanen A, Motoyama J, Hui CC. Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embryogenesis. Int J Dev Biol. 1999;43(6):487-494.